周付涛导师简介

周付涛导师简介

周付涛，男，汉族，中共党员，副教授、硕士生导师，研究方向为神经疾病。现为赣南医学院基础医学院生理学教师，江西省生理学会理事。 

2011年四川大学获得医学生理学博士学位。2012-2019年供职于浙江丽水学院，2019年调入赣南医学院。现主持国家自然科学基金地区项目1项，主持完成浙江省、江西省自然科学基金和赣南医学院人才启动基金等基金资助项目多项。  

研究重点关注神经退行性疾病特别是阿尔茨海默病（AD）的遗传学及其风险因子研究，重点关注炎症因子在AD中发病作用及其机理。已发表论文14篇，在AD发病的分子机制及基于证据的临床研究方面以第一作者身份发表SCI论文7篇，其中一区2篇，论文收录于《Ageing Research Reviews》(IF：10.616)、《Advances in Nutrition》（IF：9.2）、《Alzheimer's research & therapy》（IF：9.0）、《Journal of Alzheimer’s Disease》、《Journal of Neuroscience Research》等国际著名杂志。以第一作者在国际重要衰老学术期刊《Ageing Research Reviews》发表论文，迄今已被广泛引用。为《Journal of Alzheimer’s Disease》杂志associated editor，《Human & Experimental Toxicology》、《NeuroMolecular Medicine》、《World journal of psychiatry》特邀审稿人。

现指导硕士研究生5名，毕业4名，1名在读。  

第一作者（或通讯作者）SCI论文：

(1)IL-1β neutralization ameliorates cognitive deficits and tau pathology in a mouse model of Alzheimer's disease with Hyperhomocysteinemia, Experimental Neurology, 2026, 115729

(2)Neuroinflammatory chemokine networks in transgenic models of Alzheimer's disease: A comparative multi-compartmental analysis, Hum Exp Toxicol, 2025, 44, 744600333

(3)Homocysteine and multiple health outcomes: an outcome-wide umbrella review of meta-analyses and Mendelian randomization studies, Advances in Nutrition, 2025, 16(6), 100434.

(4)Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer’s Disease, Journal of integrative neuroscience, 2024, 23(11), 197.

(5) Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis, Alzheimer's research & therapy, 2023, 15(1), 107.

(6) Effect of antioxidant intake patterns on risks of dementia and cognitive decline, European Geriatric Medicine, 2023, 14(1), 9-17.

(7)Blood and CSF Homocysteine Levels in Alzheimer's Disease: A Meta-Analysis and  Meta-Regression of Case-Control Studies, Neuropsychiatric Disease and Treatment, 2022, 18, 2391-2403

(8) Hyperhomocysteinemia and risk of incident cognitive outcomes: an updated dose-response meta-analysis of prospective cohort studies, Ageing research reviews, 2019, 51: 55-66.

(9) Effects of gender and other confounding factors on leptin concentrations in Alzheimer's disease: evidence from the combined analysis of 27 case-control studies, Journal of Alzheimer's Disease, 2018, 62(1): 477-486, 2018 IF 3.517.

(10) The bridging integrator 1 gene rs7561528 polymorphism contributes to Alzheimer's disease susceptibility in East Asian and Caucasian populations, Clinica Chimica Acta, 2017, 469: 13-21.

(11) Luteolin reduces zinc-induced Tau phosphorylation at Ser262/356 in an ROS-dependent manner in SH-SY5Y Cells, Biological Trace Element Research, 2012, 149(2): 273-279.

(12) Reactive oxygen species mediate abnormal Tau phosphorylation in a zinc-induced model, Journal of Neurological Sciences (Turkish), 2015, 32(1): 115-121.

(13) Luteolin protects against reactive oxygen species-mediated cell death induced by zinc toxicity via the PI3K-Akt-NF-kappaB-ERK-dependent pathway, Journal of Neuroscience Research, 2011, 89(11): 1859-1868.

联系方式：

地址：江西省赣州市赣南医学院黄金校区基础医学院生理学教研室

Email: zhft522@163.com